Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Wallerian Degeneration

5,7-dihydroxytryptamine has been researched along with Wallerian Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hatzidimitriou, G; McCann, U; McLane, MW; Ricaurte, G; Tong, L; Xie, T; Yuan, J	1

Other Studies

1 other study(ies) available for 5,7-dihydroxytryptamine and Wallerian Degeneration

Article	Year
Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:12 Topics: 5,7-Dihydroxytryptamine; Animals; Axons; Brain; Down-Regulation; Fenfluramine; Immunohistochemistry; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Wallerian Degeneration	2006

Article

Year

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:12

Topics: 5,7-Dihydroxytryptamine; Animals; Axons; Brain; Down-Regulation; Fenfluramine; Immunohistochemistry; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Wallerian Degeneration

2006